Detail page

Knowledge Web

Person

Jochen Bodem

Virologe

Name	Jochen Bodem
Time	21. Jh (Wirkungsdaten)
Place	Deutschland
Gender	männlich
Academic degree	Dr. rer. nat. (an der Univ. Heidelberg) (1998)
Profession	Virologe (characteristic profession)
Further information	Habil. Fach Virologie an der Univ. Würzburg (2005)
Record type	Person
GND-Identifier	1023613441
Record ID	1023613441
Involved in show all Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors Enolase 1 of Candida albicans binds human CD4 + T cells and modulates naïve and memory responses Acetylsalicylic acid and salicylic acid inhibit SARS-CoV-2 replication in precision-cut lung slices Azido-ceramides, a tool to analyse SARS-CoV-2 replication and inhibition — SARS-CoV-2 is inhibited by ceramides Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors Enolase 1 of Candida albicans binds human CD4 + T cells and modulates naïve and memory responses Flt3L, LIF, and IL‐10 combination promotes the selective in vitro development of ESAM\(^{low}\) cDC2B from murine bone marrow Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2 The acid ceramidase is a SARS-CoV-2 host factor Flt3L, LIF, and IL‐10 combination promotes the selective in vitro development of ESAM low cDC2B from murine bone marrow Facile synthesis and in vitro activity of N-substituted 1,2-benzisothiazol-3(2H)-ones against dengue virus NS2BNS3 protease SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro The Manifold Roles of Sphingolipids in Viral Infections The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue Die Hauptprotease von SARS‐CoV‐2 als Zielstruktur: Von der Etablierung eines Hochdurchsatz‐Screenings zum Design maßgeschneiderter Inhibitoren Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors The SARS-CoV-2 RNA–protein interactome in infected human cells Regulation der foamyviralen Genexpression Molekulare Klonierung und transkriptionelle Charakterisierung des felinen Spumaretrovirus

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Jochen Bodem

Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific

Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors

Enolase 1 of Candida albicans binds human CD4 + T cells and modulates naïve and memory responses

Acetylsalicylic acid and salicylic acid inhibit SARS-CoV-2 replication in precision-cut lung slices

Azido-ceramides, a tool to analyse SARS-CoV-2 replication and inhibition — SARS-CoV-2 is inhibited by ceramides

Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors

Enolase 1 of Candida albicans binds human CD4 + T cells and modulates naïve and memory responses

Flt3L, LIF, and IL‐10 combination promotes the selective in vitro development of ESAM\(^{low}\) cDC2B from murine bone marrow

Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2

The acid ceramidase is a SARS-CoV-2 host factor

Flt3L, LIF, and IL‐10 combination promotes the selective in vitro development of ESAM low cDC2B from murine bone marrow

Facile synthesis and in vitro activity of N-substituted 1,2-benzisothiazol-3(2H)-ones against dengue virus NS2BNS3 protease

SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro

The Manifold Roles of Sphingolipids in Viral Infections

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue

Die Hauptprotease von SARS‐CoV‐2 als Zielstruktur: Von der Etablierung eines Hochdurchsatz‐Screenings zum Design maßgeschneiderter Inhibitoren

Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors

The SARS-CoV-2 RNA–protein interactome in infected human cells

Regulation der foamyviralen Genexpression

Molekulare Klonierung und transkriptionelle Charakterisierung des felinen Spumaretrovirus